Abvc Biopharma (ABVC) EBT Margin (QoQ) (2010 - 2025)
Abvc Biopharma (ABVC) EBT Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65,643.00 |
| Dec 31, 2024 | -4.04 Mn |
| Sep 30, 2024 | 86,368.00 |
| Jun 30, 2024 | 24.20 Mn |
| Mar 31, 2024 | -21.87 Mn |
| Dec 31, 2023 | -303,886.00 |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | -3.51 Mn |
| Mar 31, 2023 | -87,838.00 |
| Dec 31, 2022 | 832,382.00 |
| Sep 30, 2022 | -827,573.00 |
| Jun 30, 2022 | 2.34 Mn |
| Mar 31, 2022 | -2.56 Mn |
| Dec 31, 2021 | 347,824.00 |
| Sep 30, 2021 | 473,725.00 |
| Jun 30, 2021 | -624,537.00 |
| Mar 31, 2021 | 765,516.00 |
| Dec 31, 2020 | -624,579.00 |
| Sep 30, 2020 | -89,732.00 |
| Jun 30, 2020 | 59,777.00 |